Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 20.95 | 17.78 |
PEG Ratio (TTM) | 17.31 | 4.88 |
P/S Ratio (TTM) | 8.82 | 3.13 |
P/B Ratio (TTM) | 2.02 | -5.83 |
P/FCF Ratio (TTM) | 24.67 | 29.55 |
Price to 5YR AVG Earnings Ratio | N/A | 31.82 |
Price to 5YR AVG FCF Ratio | N/A | 17.19 |
Profitability (40%) |
Company | Industry |
---|---|---|
ROA (TTM) | 4.51% | 1,150.53% |
ROE (TTM) | 9.77% | -422.96% |
Net Profit Margin (TTM) | 42.10% | 18.52% |
ROIC 5YR AVG | N/A | 9.20% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 3.00% | 13.24% | N/A |
Revenue | 2.19% | 21.64% | N/A |
Net Income | 3.03% | 13.22% | N/A |
Cash Flow | 10.50% | 19.18% | N/A |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.84 | 0.88 |
Quick Ratio (TTM) | 0.84 | 0.71 |
D/E Ratio (TTM) | 0.75 | -3.28 |
Interest Coverage (TTM) | 3.19 | 3.61 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | 1.55 | 1.42 |
LTL to 5YR AVG FCF | N/A | 4.92 |
Shares Outstanding Growth 5YR AVG | N/A | 6.52% |